| Author | Title | Source | Year |
| Wang YC, Tsai MC, Chen YS, Hsieh PM, Hung CM, Lin HY, Hsu YC, Yeh JH, Hsiao P, Su YC, Ma CH, Lee CY, Lin CC, Shu CW, Li YC, Tsai MH, Lin JY, Peng WH, Yu ML, Lin CW. | NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression. | Hepatol Commun. 2022 Nov 2. doi: 10.1002/hep4.2019. Epub ahead of print. | 2022 |
| Jen-Hao Yeh, Ching-Tai Lee, Min-Hung Hsu, Chi-Wen Lin, Po-Jen Hsiao, Chien-Lin Chen, Wen-Lun Wang. | Antireflux mucosal intervention (ARMI) procedures for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. | Therap Adv Gastroenterol. 2022 Apr 29;15:17562848221094959. doi: 10.1177/17562848221094959. | 2022 |
| Jen-Hao Yeh, Wen-Lun Wang, Chih-Wen Lin, Ching-Tai Lee, Cheng-Hao Tseng, Po-Jen Hsiao, Yu-Peng Liu, Jaw-Yuan Wang. | Safety of cold snare polypectomy with periprocedural antithrombotic agents for colorectal polyps: a systematic review and meta-analysis. | Therap Adv Gastroenterol. 2022 Feb 10;15:17562848211070717. doi: 10.1177/17562848211070717. | 2022 |
| Jen-Hao Yeh,Tsung-Chin Wu,Po-Jen Hsiao,Daw-Shyong Perng,Jen-Chieh Chen,Gin-Ho Lo,Chia-Chang Hsu,Chih-Wen Lin. | A single-center retrospective study comparing 1-day and 3-day low-residue diets for bowel preparation. | Adv Dig Med. 2022;1–8.DOI: 10.1002/aid2.13306 | 2021 |
| Yuan-Chen Li, Ping-Hung Chen, Jen-Hao Yeh, Pojen Hsiao, Gin-Ho Lo, TaoQian Tan, Pin-Nan Cheng, Hung-Yu Lin, Yaw-Sen Chen, Kun-Chou Hsieh, Pei-Min Hsieh, Chih-Wen Lin. | Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis. | BMC Gastroenterol. 2021 Nov 8;21(1):418. doi: 10.1186/s12876-021-01995-z. | 2021 |
| Daw-Shyong Perng, Chao-Ming Hung, Hung-Yu Lin, Paul Morgan, Yao-Chun Hsu, Tsung-Chin Wu, Pei-Min Hsieh, Jen-Hao Yeh, Pojen Hsiao, Chih-Yuan Lee, Yu-Chan Li, Ya-Chin Wang, Yaw-Sen Chen, Chih-Wen Lin. | Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection. | BMC Cancer. 2021 Jul 17;21(1):828. doi: 10.1186/s12885-021-08553-6. | 2021 |
| Chen YS, Hsieh PM, Lin HY, Hung CM, Lo GH, Hsu YC, Lu IC, Lee CY, Wu TC, Yeh JH, Hsiao P, Li YC, Wang YC, Hsieh KC, Lin CW. | Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis. | BMC Gastroenterol. 2021 May 14;21(1):220. doi: 10.1186/s12876-021-01807-4. | 2021 |
| Chih-Wen Lin, Tsung-Chin Wu, Hung-Yu Lin, Chao-Ming Hung, Pei-Min Hsieh, Jen-Hao Yeh, Pojen Hsiao, Ya-Ling Huang, Yu-Chan Li, Ya-Chin Wang, Chih-Wen Shu, Yaw-Sen Chen. | Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis. | BMC Gastroenterol. 2021 Jan 7;21(1):20. doi: 10.1186/s12876-020-01586-4. | 2021 |
| Jen-Hao Yeh, Cheng-Hao Tseng, Ru-Yi Huang, Chih-Wen Lin, Ching-Tai Lee, Po-Jen Hsiao, Tsung-Chin Wu, Liang-Tseng Kuo, Wen-Lun Wang. | Long-term Outcomes of Primary Endoscopic Resection vs Surgery for T1 Colorectal Cancer: A Systematic Review and Meta-analysis. | Clin Gastroenterol Hepatol. 2020 Nov;18(12):2813-2823.e5. doi: 10.1016/j.cgh.2020.05.060. Epub 2020 Jun 8. PMID: 32526343. | 2020 |
| Jen-Hao Yeh, Ru-Yi Huang, Ching-Tai Lee, Chih-Wen Lin, Ming-Hung Hsu, Tsung-Chin Wu, Po-Jen Hsiao, Wen-Lun Wang. | Long-term outcomes of endoscopic submucosal dissection and comparison to surgery for superficial esophageal squamous cancer: a systematic review and meta-analysis. | Therap Adv Gastroenterol. 2020 Nov 6;13:1756284820964316. doi: 10.1177/1756284820964316. PMID: 33224272; PMCID: PMC7656883. | 2020 |
| Chih-Wen Lin, Yaw-Sen Chen, Gin-Ho Lo, Yao-Chun Hsu , Chia-Chang Hsu, Tsung-Chin Wu, Jen-Hao Yeh, Pojen Hsiao, Pei-Min Hsieh, Hung-Yu Lin, Chih-Wen Shu, Chao-Ming Hung. | Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis. | BMC Gastroenterol. 2020;20(1):99. Published 2020 Apr 10. doi:10.1186/s12876-020-01235-w | 2020 |
| Hsiao P, Hsieh KC, Chen YS, Hsu CC, Lo GH, Li YC, Hsieh PM, Lin HY, Wu TC, Yeh JH, Lin CW. | Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma. | Medicine (Baltimore). 2019 Jun;98(25):e16074. doi: 10.1097/MD.0000000000016074. | 2019 |